10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,558,325 | +59.9% | 62,020 | +116.5% | 0.01% | +16.7% |
| Q2 2023 | $1,599,648 | +635.2% | 28,647 | +634.5% | 0.01% | +100.0% |
| Q1 2023 | $217,581 | -17.1% | 3,900 | -45.8% | 0.00% | -40.0% |
| Q4 2022 | $262,368 | -61.9% | 7,200 | +104.8% | 0.01% | -78.3% |
| Q2 2021 | $689,000 | -19.3% | 3,516 | -25.5% | 0.02% | -53.1% |
| Q1 2021 | $854,000 | -45.7% | 4,718 | -57.5% | 0.05% | -53.3% |
| Q4 2020 | $1,574,000 | +42.1% | 11,114 | +25.1% | 0.10% | -14.6% |
| Q3 2020 | $1,108,000 | +413.0% | 8,884 | +266.7% | 0.12% | +156.2% |
| Q2 2020 | $216,000 | – | 2,423 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |